Download Our Complimentary e-Book


This e-book, developed by the experts at McKesson, provides an overview of the use of RWE in community oncology — highlighting strengths, weaknesses and opportunities — and includes the following 5 case studies highlighting their research in the area:

  • Proving effectiveness of immunotherapy in advanced melanoma
  • Supporting avelumab approval for metastatic Merkel cell carcinoma
  • Identifying unexpected adverse events in reformulated supportive therapy
  • Using RWE to confirm clinical trial results: pertuzumab base therapy for breast cancer
  • Assessing daratumumab administration for multiple myeloma

©2019 McKesson Corp. All rights reserved.

Confidentiality notice: this e-mail message is for the sole use of the intended recipients and may contain confidential and privileged information. Any unauthorized review, use, disclosure, or distribution is prohibited.

This email was sent on behalf of McKesson by HealthEconomics.Com, 449 S. Mill View Way, Ponte Vedra Beach, FL 32082. If you don't wish to receive further Industry Leaders News Updates from us, you may immediately unsubscribe from this list here, or send your request in writing to the address above. Read more about our privacy policy here. You may also request a copy in writing using the address above.

To ensure you continue to receive emails from HealthEconomics.Com, please click here.